Advocacy is a core pillar of ERS. The Society’s involvement in advocacy is co-ordinated via the ERS Advocacy Council.
None
None
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
DFG | Research grant | D |
Umwelt- und Nachbarschaftshaus | Research grant | D |
Umweltbundesamt | Research grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Irish Rugby Football Union | Ad hoc Consultancy work | A |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
NovoNordisk | Unrestricted grant | D |
Fitbit | Unrestricted grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Astra Zeneca | honoraria for lectures, consulting | B |
Chiesi | honoraria for lectures | B |
Pfizer | honoraria for lectures | B |
MSD | honoraria for lectures, consulting | B |
Takeda | honoraria for lectures | B |
Amgen | honoraria for lectures | B |
Celon Pharma | honoraria for consulting | B |
Roche Diagnostics | honoraria for lectures | B |
Grifols | honoraria for lectures, consulting | B |
CSL Behring | honoraria for lectures, consulting | B |
BMS | consulting | B |
Sanofi | honoraria for lectures, | B |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
Astra Zeneca | congress | B |
Takeda | congress | B |
MSD | congress | B |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
Pfizer | research grant | B |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.
He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.
Eva is a specialist in respiratory diseases since 2003 and currently Head of the research Unit in Respiratory Infections of the Department of Respiratory Diseases at Hospital Vall d’Hebron in Barcelona.
Eva’s main lines of investigation are non-cystic fibrosis bronchiectasis, cystic fibrosis, and antimicrobial resistance.
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |